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As the result of a long search for a depigmenting mouse 
that could serve as a model for the study of vitiligo , we 
have located a strain that arose from the C57BLl6j. Its 
provisional genetic designation is C57BLl6] Ler-vitlvit. Tllis 
vitiligo mouse has congenital dorsal and ventral white spots 
(piebaldism) as well as progressive replacem ent of pig-
mented hairs by white hairs with each spontaneous m olt 
or after plucking . The lack of pigment is due to the absence 
of melanocytes from the amelanotic hair follicles and ep-
idermis . As in human beings and the Smyth chicken model , 
there is also diminution of ocular pigment. 
Reciprocal skin transplants between C57BLl6] and vit-
Rapid progress can be made in the understanding of a di sorder that occurs in human beings when an ex-perimental animal model is available for stud y. T he history with rega rd to an animal model fo r vitiligo does not go back far. Until about 15 years ago most 
physicians considered vitiligo to be a disorder exclusive to human 
beings. From our own search we now realize that probably all 
vertebrates with melanin pigmentation can develop vitiligo. There 
are examples o f the typical pig ment loss around eyes, nostrils, 
mouth , and fo otpads in dogs, ca ts, horses, pigs, and elephants 
[1-3J. Progressive depigmentation also occurs in chi ckens [4-6) 
and fi sh. In human beings, vitiligo is a disorder that is important 
m edi cally for a number of reasons: the emotional impact of this 
cosmetically disfi g uring condition on patients and their fa milies 
is severe [7J; w e must explain the high incidence o f depigmen-
ta tion in patients with a variety of autoimmune disorders [1 J; 
vitiligo may lead to impaired vision [8J; and the incidence of 
v itiligo is increased in patients with melano mas [9J. 
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iligo mice, and transpl ants in to nude mice, sugges t a pro-
g rammed pi gment cell death in the vitiligo mice. Like hu-
man beings with vitiligo, maximally depigmented viti ligo 
mice have a decreased contact sensiti vity response in com-
parison to age-matched C57BL/6] controls. The res istance 
to ir~j ec ted B16 melanomas is lowered. Vitiligo mice show 
no signs of premature aging. 
Already at this earl y stage in the study of this new animal 
model, there are findings that open a range of new ap-
proaches to the stud y and trea tment of patients w ith vitiligo 
and melano mas. J Inv est D el'mato/ 87:299-304, 1986 
The loss of skin color in vitiligo is due to the disappearance of 
epidermal pigment cells [1 0]. T he precise mechanism of thi s elim-
ination o f melanocytes is not known, but immunologic fac tors 
may playa role with geneti c, neural, and chemi cal factors con-
tributing . It is likely that knowledge rega rding the mechan ism of 
melanocyte des truction in vitiligo can be used in trea ting patients 
with melano mas. To understand pigmcnt cell loss in relation to 
autoimmunity and proli fe ration of malignant melanocytes we 
need a labo ratory animal in which vitiligo and melanomas can 
be combined . 
There are excellent experimental models fo r melanom!ls in mice 
(Cloud man S91, B1 6, and H arding Passey), hamsters (Fo rtner, 
Greene, and Bomirsky), and fis h (Anders) . Melanomas from these 
animals have been used extensively and p rodu cti vely fo r the stud y 
of the genetics and molecular biology o f melano ma cells, melanin 
biosynthesis, and mechanisms o f cellular responses to horm ones 
[11 ,12J. T he mouse and hamster melanomas arose spontaneously 
and have been propaga ted by transfer, first in animals and later 
in cell culture. Animals with a co mbination of melanomas and 
integumental pig ment loss include Arabian, Lippinzaner, and other 
gray horses [3, 13] as well as the Sinclair [1 4J and Duroc§ pigs . 
These large animals are impracti ca ble fo r the laboratory studies 
that need to be done. 
T he bes t studied experim enta l model for vitiligo is the Smyth 
chicken [4-6J. Beginning 12 yea rs ago j . Robert Symth and his 
associates at the Uni versity o f M assachusetts, Amhers t, esta b-
lished a line of chicken by selecti vely breeding birds for their 
ability to depigment progressively. Associated w ith the amela-
nosis are blindness and thyroidi tis and a hypersensitivity to im-
munologic chall enge. B ursccto my delays and injection of Cy-
c1osporin A blocks the amelanosis [1 5, 16]. A lready prior to the 
onset of depigmentation there are fi ne-s tructural and enzy mic 
abnormalities that suggest a defect inherent to melanocytes. Also, 
in comparison with control chi cken melanocy tes, the melanocytes 
cultured from the neural cres ts of Smyth chi cken embryos pro-
§Hordinsky M K, Ruth G, C utler B, Savino D, King R, Goltz R: Tu mor 
regress ion and depigmentation: simul ta neous occurrence in Duroc Swine 
with cutaneous melanocytic tumors (personal co t:n lll unica tion to ABL). 
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liferate poo rl y and develop large, pigmented autoph agosomes 
whi ch are si mil ar to those in moribund Smyth fea ther melano-
cytes [6] or in some of the melanocy tes at the depigmentin g 
borders of w hite spots in patients with vitiJj go . It is no t known 
w hether in the Sm yth chicken th e abnorm all y fun ctionin g mel-
anocytes evoke a response from a normal immun e system , w hich 
th en becomes unbalanced causing the birds to become hypersen-
sitive, or w hether bo th the melanogenic and the immune sys tems 
are defective a prio ri. T hus, there is a useful experim ental model 
fo r vitili go in a chi cken, but no chicken has been found with a 
melanoma. 
To stud y the parameters involved in the destruction of beni gn 
and malignant melanocytes, and to be able to develop an effective 
immunologic trea tment fo r patients with melanom as , we need a 
mouse th at is predisposed to gettin g vitiligo and can be used in 
conjunction w ith the mouse models fo r melanom as . For m ore 
than 10 years we have been searching for a murine strain with 
vitiligo . We have checked throughout the world with individual 
in vestigators and w ith directors of laboratories that breed mice. 
We found 6 depigmenting strains- 4 from the USA, 1 from Great 
Britain , and 1 from Australi a. 
O ne of these strains (Fig 1), provided by Dr. Elizabeth S. 
Ru ssell at T he Jackson Laborato ry, Bar Harbor, Maine, may 
enable us to develop th e model we need. The depigmentation 
mutation occurred spontaneously in the C 57BLl6j(B6) strain and 
is inherited as a simple recessive trait . The mouse, which we 
named C57BLl6j Ler-vit/ vit, II hereafter referred to as the vii/ viI 
or vitiligo mouse, shows congenital white spotting on its back 
and abdo men (Fig 1A ) as well as progressive graying of the pig-
mented areas w ith each spontaneous hair molt (Figs 1B, 2) or 
after plucking (Figs I e, 2) . 
MATERIALS AND METHODS 
Animals C57BLl6j (B6) and vitiligo mice w ere purchased from 
The j ackson Laborato ry, Bar H arbor, M aine approximately 6 
years ago and propagated in our own animal care fa cilities. 
Hair Counts H airs were plucked from the dorsum of each 
mouse and taped to microscope slides . With the aid of a trans-
mission pho tomicroscope, at a magnification of 400 X, the hairs 
were counted and categorized as pigmented o r amelanoti c. 
Skin Transplants Four-week-old , sex-matched vil/ vit , B6, or 
nude mi ce were anesthetized w ith 5% sodium pentobarbital, and 
3- to 5-mm grafts were taken from the dorsal and ventral regions, 
placed in H anks' balanced sa lt solution with penicillin / 
streptom ycin , and cleaned of adipose tissue. Multiple grafts (gen-
erally 4, from a to tal of more th an 200) were transpl anted onto 
prepared recipient hosts, in these permutations: B6 onto vit/ vil 
or nude (on BALB/c or B57BLl6 background); B6 onto B6; viI/ vii 
pigmented onto vil / vit piebald and vice versa ; vit / vit pigmented 
onto B6 or nude; vil/v it piebald onto B6; nude onto nude. The 
host mice were bandaged fo r 10 days, after which time the ban-
dages were removed and the coat colo r of the g rafts was observed 
at weekl y in terva ls, some up to a to tal of 25 weeks posttrans-
plantation. 
Injection of Cultured Melanoma Cells B1 6 murine mela-
noma cells were maintained in F-1 0 medium supplemented with 
7% Nu-Serum and 3% fetal calf serum (FC S) . They were har-
vested w ith EDTA, rinsed , and injected as a suspension in F-10 
medium. In one experiment, 16-week-old female viI/ viI and B6 
mi ce (n = 9 each) were inj ected with 5 X 106 melanoma cells 
into the dorsal surface of the right ea r and 1 X 106 cells into the 
dorsal surface of the left ear. In another experiment, 12-week-old 
female viI / viI and B6 mice (n = 5 each) were inj ected w ith 2 X 
106 cells into the dorsal surface of both ea rs. Tumor growth was 
assessed in terms of tumor diameter: 
II Pro visional designation, to be announced in M Ol/Sf News Leller Feb-
ruary 1986. 
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Figure 1. Pho tographs of C57BLl6J- Viti Vit normal (B6) and viti viI mu-
tant (vitiligo) mice. A , Age 3 weeks. Lefl, vili llil; righI, B6. In addition 
to a piebald abdomen this viI I viI mouse has a dorsal piebald spot at the 
nape. The basic hair color at birth of the mutant mice is lighter than that 
of the B6 control mice. B, At 2 years o f age this vitiligo mouse has los t 
almost all of its integumental pigment . Age of B6 mouse, 1 year. C , A 
vitiligo mouse (age 7 months), 3 w eeks after the hairs were plucked from 
the middorsal region. In this animal. the pro portion of amelanotic hairs 
in the regrowth is highes t in the cranial region. 
Experimental metas tases were determined by injecting 4 X 105 
B1 6 melanoma cells into the tail veins of 16-week-old fem ale 
viI / vii and B6 mice. At 14 days postinj ection , the mice were 
sacrifi ced, the lungs harvested, and pulmonary surface nodules 
counted with the aid of a dissectin g microscope. 
Testing for Contact Sensitivity Response Age-matched mice 
were sensiti zed by epicutaneous application of dinitrofluoroben-
zene (DNFB) , 0.5% in a mixture of o live oil in acetone 1 : 4, on 
shaved back or abdomen. Five days later, 0 .2% DNFB was ap-
plied to the ears and ear swelling was measured 24 h later. 
RESULTS 
Phenotype The natural g rayin g of the pigmented areas can be 
ca tegorized into 2 form s: congenital and acquired. At initial hair 
growth , the hairs are uniformly lighter than their B6 counterparts 
(Fig 1A) . The subsequent, progressive graying is due to a g radual 
replacement of pigmented hairs by amelano tic, completely white 
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Figure 2, Progressive loss of pig mentation in the pelage of vitiligo mice 
before and 2 weeks afte r plucking of do rsa l hairs. Telogen hairs (so lid bars) 
and subsequent 2-week-o ld regenerating. anagen hairs (hatched bars). Each 
bar represents approximately 300 hairs. The encircled 1IIIIIIerais deno te the 
number o f an imals in each group. T he lille bars indica te the range of 
percentages w ith in the respective batches of hair. 
hairs during successive molts (Fig 2). D uring the period of natural 
graying, dopa- reactive melanocytes disappea r from the hair fo l-
licles and epidermis [1 7], as seen by light microscopy. Electron 
microsco py of ear epidermis durin g aging [17] and of amelanotic 
hair bulbs after plucking (Boissy, to be published) has confirmed 
the absence of pigment cells. Vitiligo mice have no outward signs 
of premature aging nor do they have a shortened life span. 
The pigmented portions of newborn vitiligo mice have a uni-
formly dark g ra y color th at differs little from animal to animal, 
but the rate of replacement of pigmented by amelanotic hairs 
differs among individuals (Fig 2). Pluck ing hairs from vitiligo 
mice promotes the regrowth of amelanotic hairs in the plucked 
areas (Fig 1 C), and this induced gray ing shows a wider range of 
variation among animals of the same age than occurs during the 
normal course of graying (Fig 2). 
As in humans with vitiligo , there is irregularity of ocular pig-
ment (Boissy, to be published): in adult g ray mice, in the posterior 
portion of the cye cup , irregular amelanotic patches are apparent 
macroscopically with backlighting of the eye. Histologically, these 
patches are largely devoid of melanin . In the ' pigmented areas 
most of the melanocytes are histologicall y normal. 
In newborn vitiligo mice, in contrast to B6 mice, there is as 
yet no uvea l pigment. Some pigment appears in the iris and ciliary 
body by da y 4 and in the choroid by week 3. Accompanying the 
delayed onset of pigmentation is the appea ran ce of conspicuous, 
spherical, amelanotic cells, first along the anterior surfa ce of the 
iris, later also in the ciliary body and stro ma. These cells become 
numerous in the ens uing weeks and gradually acquire large mel-
anophagosomes. Whether or not the spherica l cells contain mel-
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anin , th cy have numerous surface ruffles and are larger than mel-
anocytes. They probabl y are macrophages. 
N o tests of visual acuity have bccn perfor med on vitiligo mice. 
In contrast to the Smyth chi cken, thc eyes of vitiligo mice remain 
dark to the unaided observer, even in maximally depigmented 
animals. 
Inheritance T he viti li go mousc is the on ly murine example 
known in w hi ch congenital spotting (piebaldism) and vitiligo 
occu r together. In white-spotted, ca rl y graying horses no cor-
relation has been fo und betwcen these 2 traits [13]. We have 
confirmed that the white spotting and the ca rly g raying pheno-
types in the vitiligo mouse are inherited together as a recessivc 
trai t (Ta ble I). N evertheless, there arc va riations in the express ion 
of both tra its. Whi te spo tting ranges from approximately 8- 46% 
of the animals' total pelage. Selective pressure on the ex tent of 
piebaldism did not result in segregation of that trait nor did it 
influence thc rate of the associated viti ligo. It is possible that the 
w hi te spotting is not cl ass icall y reccssive: outcrossing and back-
crossin g of the vil/ll it line to the B6 line resulted in w hite ab-
dominal spots ranging in diam ctcr from t\;" -t" in approximatel y 
50% of the progeny (Table I). 
Reciprocal Skin Transplants Between B6 Normal and IIitfllit 
Mice, and Transplants to Athymic (Nude) Mice Sera from 
patients with vitili go contain an tibod ies directed agai nst mela-
nocytes [1 8,19]. The question as to whether these antibodies con-
tribute in the ki lling of pigment cells rcmains to be answered. 
Paticnts with melanomas who develop viti ligo have an extended 
li fe span in comparison with those who do not [20]. If an immune 
response directed against mclanocytes is responsible fo r the de-
struction of pigment cells in patients with vitiligo or with vitiligo 
and melanoma, and in the vit/ll il mice, onc might ex pect that the 
hair color of B6 skin grafted onto th e histocompatible vitiligo 
micc during the period of their progressive depigmcntation would 
lighten. T his is not the case, but rather the opposite is true, Pieces 
of skin were taken from the back or abdomen of donor' mi ce and 
gra fted onto the back or abdomcn of sex-matched recipient mice 
[21 J. Whcn dorsal o r ventral B6 sk in was transplan ted to similar 
sites on B6 mice, young gray ing vitiligo mice, mature gray 
vitiligo mice, or nude mice, the hair color of the grafts remained 
black for as long as 16 weeks (Fig 3A,D). When vit/v it skin from 
mature g ra y or yo ung ea rl y graying mice was g rafted onto the 
back or abdo men of B6 mice or nud e mice, all hair in the g rafts 
turned wh ite (Fig 3A,D). When viI/v iI skin from ea rly g raying 
mice was g rafted onto the back or abdomen of other early graying 
mice, some of th e g rafts retained their original color for as long 
as 13 weeks (Fig 3C) whereas others turned w hi te. 
T hese findin gs show th at, contrary to our originial assum ption, 
vitiligo mice do no t des troy histocompatible control pigment cells 
and may, in fac t, provide a supporti ve environment for the limited 
survival of their own melanocy tes. That the loss of vil/ llil mel-
anocytes in B6 hosts is not necessaril y due to an immune response 
aga inst them is indi ca ted by the equally effective whitening of 
the lIil/vil grafts on th e immunologica ll y compromised, nude 
mice. Barring the remote poss ibility of local transfer of long-
Table I. Inheritance of Gray ing and Piebaldism in Vitiligo Micc 
Parents % Graying % Black 
Oil/cross to C57BL16) 
vili llit X C57BLl6J o 58 
F l (WAS) X Fl (no WAS) 26 48 
[1 2 
F2 Backcl'oss to C57BL16) 
F2 Black (W AS) X C57BLl6] o 94 
F2 Black (no WAS) X C57BLl6J o 40 
Progeny 
% Black w ith White 
Abdominal Spot (WAS) 
42 
26 
1J 
6 
60 
Number 
of Mice 
52 
65 
18 
5 
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Fig ure 3. Reciproca l skin transplants between 
B6 and vitiligo mjce and transplants onto nude 
mice. A, B6 (a rrow) and vir /v iI pigmented (ar· 
rowh ead) onto B6 (16 weeks). B, B6 onto vir /v ir 
(14 weeks). C, vir/vir pigmented onto vir /v ir (14 
weeks) . D , Pigmented vii /v iI (b lack arrows), B6 
(b lack arrowhead), and nude (whire an'owhead) onto 
BALB/c nude (> 16 weeks). 
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Figure 4. Vir/viI and B 16 melanomas (I). Co mparative size of experi-
mental tumors. T he vir/v ir mice were in the period of progressive depig-
mentation. 
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acting, graft-indigenous immune factors during grafting, these 
findin gs make it appea r unlikely that vitiligo in the lIitlvit mouse 
is an autoimmune disease in the common sense of the concept. 
Rather, these findings point to the possibility of a primary 
melanocytic dysfunction in the etiology of the acquired amelan-
osis. This idea is supported by the documented d ysfunction of 
melanocytes in the Smyth chicken [6] and by the clinical impres-
sion that patients with vitiligo respond more favorably to chem-
ical depigmenting agents than do individuals who do not have 
vitiligo. The data also go along with the paucity of cellular in-
filtrates noted in the borders of advancing lesions in patients with 
common vitiligo [22] and suggest that the melanocyte-binding 
antibodies found in such patients may be a consequence rather 
than the cause of cell injury . 
Vitiligo Mice and Melanomas We have suggested on the basis 
of clinical and epidemiologic fll1dings in families with both vitiligo 
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Figure 5. Vit/vit mice and B16 melanomas (II). Comparative number of 
experi mental metastases . Again , the vitiligo mice were in the period of 
progress ive depigmentation. 
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and melanomas that the melanocytes of people with vitiligo or 
with a genetic background for vitiligo may be predisposed to 
becoming transformed to melanomas [20]. Another hypothesis 
would be that melanocytes , once transformed, find a favorab le 
growth environment in the vitiligo patient, but, originating from 
inherently defective cells, the vitiligo melanomas grow less rap-
idly. If these hypotheses are correct and held to be the case with 
the vitiligo mouse, one would expect the incidence of spontaneous 
melanomas and the growth rate of exogenously administered B 16 
melanomas to be higher in vitiligo mice than in the B6 controls. 
Because mice in general are not known to have a high incidence 
of spontaneous melanomas, we decided to test the second hy-
pothesis, knowing full well that melanoma cells derived from 
other than vit/vit mice may tell only half the story. 
The growth rates and the incidence of metastases of exoge-
nously administered melanomas were determined in 12- to 16-
week- old B6 and in vit/vit ·mice. After local injection of cultured 
BI6 melanoma cells, tumors grew significantly faster in the de-
pigmenting vit/ vit mice than in age- and sex--'matched B6 controls 
(Fig 4). Also, the vitiligo mice died earlier than relevant con trols. 
Metastases were determined by injecting melanoma cells into the 
tail vein and coun ting pulmonary surface nodules. The number 
of nodules in the vitiligo mice was more than double that in the 
B6 mice (Fig 5). 
When similar experiments were performed w ith younger mice, 
6-7 weeks of age, before the time of onset of depigmentation in 
the vit/v it mice, the differences between vit/vit and control B6 
mice were less pronounced. These results indicate that during the 
period of progressive depigmentation vitiligo mice favor, or are 
impaired in their ability to restrict, the growth ofB16 melanoma 
cells at the dosage administered. 
Contact Sensitivity in B6 Nonnal and vitlvit Mice Contact 
sensitivity tests with dinitrochlorobenzene (DNCB) on patients 
w ith vitiligo revealed that the response to challenge was dimin-
ished in the depigmented patches of skin regardless of whether 
sensitization was performed on pigmented or dep igmented areas 
[23]. Because we know that the pigmented skin of vitiligo patients 
cannot be considered normal and be used as a control (22), we 
have extended these experiments and have found that patients 
with viti ligo in general have a lower contact sensitivity response 
to DNCB than individuals who do not have vitiligo (Huberman, 
Jacobson and Lerner, to be published). . 
Sex-matched B6 and vit/vit mice, before the onset of depIg-
mentation in the vitiligo mice, were sensitized with DNFB and 
challenged as outlined in Materials arid M ethods . B6 and vit/vil 
mice responded equally to the challenge dose regardless of the 
sensitization site (Table II). This experiment shows that the con-
Table II. Contact Sensitivity Response to DNFB in 
C57BLl6] (B6) N ormal and vit/vit Mutant Mice 
Sensitization Site Age (weeks) 
Back 9" 
24& 
35' 
Abdomen' 9" 
24& 
35' 
Increase in Ear T hickness 
(mm x 10 - 2) 
B6 "it/"it 
17.4 17.7 
26.5 19.4 
15.3 6.4' 
16.9 15.5 
23.0 16.6 
13.3 5,S'1 
A total of36 mice were sensitized with DNFB 0.5% on shaved back or abdo men. 
Five days later, 0.2% DNFB was applied to the ears and car swelling was measured 
24 h later. 
'Befo re the onset of depigmentation in the vitiligo mice. 
'During the period of pigment loss. 
'After maximal depigmentation has occurred. 
'p < 0.005 between controls and mutants. 
'Pieba ld in the vit iligo mice. 
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genital lack of melanocytes in the piebald abdominal skin of vit/vit 
mice does not affect the bulk antigen-presenting ability of the 
epidermis or the elicitation of the responses to DNFB contact 
sensitization. 
On the other hand, maximally depigmented vitiligo mice at 35 
weeks of age exhibited a decreased contact sensitivity response 
as compared with their B6 controls regardless of the site of sen-
sitization (Table II) . These results provide a defini te indication 
for an immune dysfunction in the older vitiligo mice . 
COMMENT 
From the results of experiments presented in this paper, it is likely 
that we have a mouse model for vitiligo. Having 2 animal models, 
the chicken and the mouse, plus being able to grow nonmalignant 
pigment cells in culture means that the basic tools are in hand to 
study the etiology of vitiligo as well as to understand the im-
portant relationship between vitiligo and melanomas. 
We thallk Dr. Aki!Jiko Tamllra for critical readillg of the Illall/IScript aI'ld Ja ck 
Schreiber for skillji,1 secretarial assistallce. We are indebted to Dr. Michael R. 
Lel'ller fo r SJlggestillg the transplallts i,Jto III/de mice. 
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